martedì 7 marzo 2017

Cannabis Science Inc (OTCMKTS:CBIS) To Attend Global Health Catalyst Summit At Harvard Medical School

Cannabis Science Inc (OTCMKTS:CBIS) has announced that it would be represented by its CEO, Raymond C. Dabney, at the Global Health Catalyst Summit, due to be held at the Harvard Medical School, on April 28-30, 2017. The company stated that Mr. Dabney would be a keynote speaker, at the summit and would also be a part of the panel. Added to this, the CMO of CBIS, Allen Herman, has also been invited to the summit, to co-chair a special session at the summit.
It should be noted here that Cannabis Science and the Harvard Medical School have a close working relationship. Mr. Dabney and Mr. Herman, have previously visited the school and delivered presentations about the rapidly developing medical cannabis industry. Further details from the company have revealed that Mr. Dabney has been asked to be a keynote speaker and panelist for a special session on “Cannabis Science Versus Cancer and Other Malignancies.”
In addition to this, Mr. Dabney plans to use the summit as a platform for providing an overview of the company, its drug development programs and the ongoing collaborative research agreement between the school and the company. CBIS is viewing the summit as an opportunity to discuss some of its cutting edge research, with the top minds in the medicinal industry. Moreover, the company also plans to establish partnerships, with institutions, present at the conference.
Mr. Dabney expressed his excitement about the potential partnership with the Dana-Farber Research Center, at Harvard Medical School. He claimed that his meeting with Wilfred Ngwa, the director of global health catalyst, at the center, had led to the immediate realization of potential synergies, in cancer research. The two had first met in September 2016, at the annual Constituency For Africa summit and went on to develop a research partnership in later months.
Cannabis Science Inc (OTCMKTS:CBIS) completed the March 3 trading session with a gain of 3.87% in terms of its share value, to close at $0.094 per share. The stock had a trade volume of 34.72 million, during the session.

Nessun commento:

Posta un commento